Key result
Single-access transfemoral TAVI linked to ~54% lower odds of 30-day adverse events vs. dual access.
Why the study?
Single-access transfemoral TAVI reduces the need for multiple vascular access and related complications, but the impact of patient age on its clinical outcomes remains uncertain.
Does single-access transfemoral TAVI reduce 30-day MACE and improve safety compared to dual-access TAVI in patients with severe aortic stenosis, particularly in the elderly?
Observational (n=204)
No
Does single-access transfemoral TAVI reduce 30-day MACE and improve safety compared to dual-access TAVI in patients with severe aortic stenosis, particularly in the elderly?
Single-access transfemoral TAVI is associated with a significant reduction in 30-day major adverse cardiovascular events compared to dual-access TAVI, particularly in elderly patients aged 84 and older.
Answers are grounded in this paper and cite their sources.
May support single-access TAVI to lower early MACE in elderly patients; leaves open confirmation in randomized trials.
Background: Single-access transfemoral transcatheter aortic valve implantation (TAVI) reduces the need for multiple vascular access and therefore, the related risk of related complications. However, the impact of patient age on its clinical outcomes remains uncertain. Methods: This is a secondary analysis of previously reported propensity score matched study comparing clinical outcomes of single- versus dual-access transfemoral TAVI using SAPIEN-3-Ultra. We examined the relation between patient age, access strategy and outcomes—specifically, 30-day safety endpoint according to the Valve Academic Research Consortium 3 (VARC-3) and major adverse cardiovascular events (MACE), defined as death, permanent pacemaker, neurological or vascular complications—using logistic regression interaction analyses, and restricted cubic spline modelling. Results: A total of 204 patients (propensity score-matched cohort) were included in the study. The elderly group were more likely to have hypertension, peripheral vascular disease or stroke. The use of single access was comparable. The elderly cohort demonstrated a tendency toward longer fluoroscopy and procedural times compared with the non-elderly group. This pattern likely reflects the greater technical complexity and heightened procedural caution often associated with older patients, including more challenging vascular anatomy and the need for careful device handling. Although not statistically significant, these findings remain clinically meaningful and are consistent with the notion that procedures in elderly patients frequently require more meticulous planning and execution. There was a significant interaction between access strategy and age in reducing MACE, but not in VARC-3 safety outcomes. Single access was associated with a significant reduction in MACE (5.4% vs. 26.7%, p = 0.015) with comparable technical and safety outcomes when compared with elderly patients who underwent dual-access TAVI. Conclusions: Single-access TAVI was linked to favourable early outcomes, maintained procedural success, and suggested a possible age-dependent pattern in the occurrence of MACE. Our findings support the need for randomised studies to demonstrate superiority of single- versus dual-access TAVI, particularly in the elderly population.
No takes yet. Share an insight, caveat, or question.
Saluja et al. (2026) conducted an observational in Severe aortic stenosis (n=204). Single-access transfemoral TAVI vs. Dual-access transfemoral TAVI was evaluated on 30-day safety (VARC-3) (OR 0.46, 95% CI 0.23 to 0.92, p=0.028). Single-access transfemoral TAVI was associated with significantly better 30-day safety (OR 0.46) and reduced MACE compared to dual-access TAVI, with a pronounced MACE reduction in elderly patients.
Synapse has enriched 10 related papers. Consider them for comparative context: